Standard cardiac rehabilitation is less effective for diabetics

Related Experiment Video

Updated: Oct 4, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

V Suresh1, R A Harrison, P Houghton

  • 1Department of Cardiology, Wigan and Leigh NHS Trust Wigan, Wigan Lane, Wigan, Lancs WN1 2NN, UK.

International Journal of Clinical Practice
|October 12, 2001
PubMed

Insights

Diabetic patients experienced poorer outcomes in standard cardiac rehabilitation programs after myocardial infarction (MI). These patients had less medication, lower smoking cessation rates, and higher mortality, suggesting a need for specialized programs.

Area of Science:

  • Cardiology
  • Diabetology
  • Public Health

Background:

  • Myocardial infarction (MI) is a leading cause of mortality globally.
  • Cardiac rehabilitation (CR) improves outcomes for post-MI patients.
  • Diabetes mellitus is a significant risk factor for cardiovascular disease and impacts CR effectiveness.

Purpose of the Study:

  • To evaluate clinical outcomes and lifestyle modifications in diabetic patients undergoing standard CR post-MI.
  • To compare the effectiveness of standard CR for diabetic versus non-diabetic patients.
  • To identify specific areas where standard CR falls short for diabetic individuals.

Main Methods:

  • Retrospective longitudinal study design.
  • Analysis of data from 1804 patients (223 with diabetes) attending CR over 10 years.
  • Comparison of medication adherence, lifestyle modifications (smoking cessation, physiotherapy), and mortality rates between diabetic and non-diabetic groups.

Main Results:

  • Diabetic patients received significantly less aspirin and beta-blocker therapy (p < 0.0001).
  • Smoking cessation rates were lower (54.2% vs 69.1%, p < 0.003) and physiotherapy attendance was reduced (26.9% vs 58.6%, p < 0.0001) in diabetics.
  • Diabetic patients exhibited higher one-year mortality (15.7% vs 5.6%, p < 0.0001), primarily due to cardiovascular disease.

Conclusions:

  • Standard CR programs are less effective for patients with diabetes mellitus.
  • Specialized rehabilitation programs are needed to integrate chronic condition management with MI care.
  • Aggressive, evidence-based pharmacotherapy should be prioritized for all post-MI patients, including those with diabetes.

Related Concept Videos

Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...